Infertility and Assisted Reproductive Technologies

Published on 10/03/2015 by admin

Filed under Obstetrics & Gynecology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1310 times

Chapter 34 Infertility and Assisted Reproductive Technologies

It is estimated that 10% to 15% of couples in the United States are involuntarily infertile. Newer reproductive technologies such as in vitro fertilization (IVF) and embryo transfer are increasing the success of treatment for this condition.

A couple is considered infertile after unsuccessfully attempting to achieve pregnancy for 1 year. Infertility is termed primary when it occurs without any prior pregnancy and secondary when it follows a previous conception. Some conditions, such as azoospermia, endometriosis, and tubal occlusion, are more common in women with primary infertility, but virtually all conditions occur in both settings, making the distinction of little clinical significance.

image Basic Evaluations

Evaluation and therapy may be started earlier when obvious defects are identified, or they may be delayed, for instance, when a correctable factor, such as infrequent intercourse, is identified.

In general, the first 6 to 8 months of evaluation involve relatively simple and noninvasive tests and the performance of a radiologic evaluation of tubal patency (hysterosalpingography, or HSG), which can sometimes have a therapeutic effect. In some studies, use of an oil-based dye about doubled the success rate after HSG. Operative evaluation by laparoscopy is thus reserved for the small proportion of couples who have not conceived after 18 to 24 months or who have specific abnormalities or indications of a probable pelvic factor.

To keep the status of the evaluation in mind, it is helpful to arrange the workup under a series of five categories that can be mentally reviewed at each visit. Table 34-1 shows the approximate incidence and the tests involved in the evaluation of each category. Box 34-1 summarizes the treatment options for infertility. In 5% to 10% of couples, no explanation can be found (idiopathic infertility).

TABLE 34-1 COMMON INFERTILITY FACTORS

Factor Incidence (%) Basic Investigations
Male, coital 40 Semen analysis
    Postcoital test
Ovulatory 15-20 Urinary luteinizing hormone self-test; serum progesterone
Cervical 5 Postcoital test
Uterine, tubal 30 Hysterosalpingogram
    Laparoscopy
Peritoneal 40 Laparoscopy

Investigations only when menses are regular (every 22 to 35 days); oligomenorrhea generally requires treatment.

image Etiologic Factors

MALE COITAL FACTOR

Investigations

A semen analysis should be performed following a 2- to 4-day period of abstinence. The entire ejaculate should be collected in a clean, nontoxic container. Until relatively recently, the full range of normal variation was not appreciated. Characteristics of a normal semen analysis are shown in Table 34-2.

TABLE 34-2 CHARACTERISTICS OF NORMAL SEMEN ANALYSIS

Characteristics Quantity
Semen volume 2-5 mL
Sperm count Greater than 20 million/mL
Sperm motility Greater than 50%
Normal forms Greater than 30% standard morphology or greater than 14% “strict” morphology
White blood cells Fewer than 10 per high-power field or 1 × 106/mL

At least 25% A motility or 40% A plus B motility.

An excessive number of leukocytes (more than 10 per high-power field) may indicate infection, but special stains are required to differentiate polymorphonuclear leukocytes from immature germ cells. Semen quality varies greatly with repeated samples. An accurate appraisal of abnormal semen requires at least three analyses. Periodic reassessment is necessary.

Endocrine evaluation of the male with subnormal semen quality may uncover a specific cause. Hypothyroidism can cause infertility, but there is no place for the empirical use of thyroxine. Low levels of gonadotropins and testosterone may indicate hypothalamic-pituitary failure. An elevated prolactin concentration may indicate the presence of a prolactin-producing pituitary tumor. An elevated level of follicle-stimulating hormone (FSH) generally indicates substantial parenchymal damage to the testes, as inhibin, produced by the Sertoli cells of the seminiferous tubules, provides the principal feedback control of FSH secretion. A response to any treatment is unlikely in the presence of an elevated level of FSH. However, the level of FSH is not helpful in predicting whether sperm will be recovered with testicular sperm extraction.

Treatment

The couple should be advised to have intercourse about every 1 to 2 days during the periovulatory period (e.g., days 12 through 16 of a 28-day cycle). Because infrequent coitus is a common contributing factor, firm advice in this regard can be beneficial. This “scheduled intercourse” can be disruptive and stressful, however, and insemination using husband or partner sperm may relieve considerable pressure on a couple.

The woman should be advised to lie on her back for at least 15 minutes after coitus to prevent rapid loss of semen from the vagina. Lubricants may be toxic to sperm. A nontoxic lubricant, Preseed, has been developed for infertile couples.

Smoking should be reduced or stopped, as should intake of alcohol. The use of saunas, hot tubs, or tight underwear should be discouraged, as should exposure to other environments that raise scrotal temperature, because these factors may affect spermatogenesis.

Low semen volume may provide insufficient contact with the cervical mucus for adequate sperm migration to occur. When a high semen volume coexists with a low count, infertility may result because a lower density of sperm contacts the cervical mucus. At present, these abnormalities of volume are most commonly treated with sperm washing and intrauterine insemination (IUI).

If low sperm density (oligospermia) or low motility (asthenospermia) is caused by hypothalamic-pituitary failure, injections of human menopausal gonadotropin (hMG) may be effective. The suppressive effects of hyperprolactinemia on hypothalamic function can be reversed by the administration of bromocriptine, a dopamine agonist. When low semen quality coexists with a varicocele (dilation and incompetence of the spermatic veins), improved semen quality, particularly motility, may occur with ligation of this venous plexus. Various medications (clomiphene, human chorionic gonadotropin [hCG], testosterone, and hMG) have been tried when no cause is apparent (idiopathic oligoasthenospermia), but none has proved effective. Because about 3 months is required for spermatogenesis and sperm transport to occur, frequent semen checks during treatment are unnecessary and serve only to discourage the patient.

If semen quality cannot be improved, IUI with close timing of the insemination to the precise point of ovulation is effective. By washing and concentrating the sperm into a small volume by centrifugation, large numbers of sperm can be placed into the uterus. Without washing, IUI must be limited to small amounts of semen, owing to marked cramping. Accurate timing may be accomplished either by measurement of daily luteinizing hormone (LH) concentrations or by controlled stimulation of the cycle with clomiphene or hMG, followed by administration of hCG when follicular diameter, as seen by ultrasonography, indicates maturity. Insemination may then be carried out within a few hours of ovulation, which occurs about 36 hours following the onset of the LH surge or hCG injection. When urinary LH testing is used, there is a delay of several hours between the onset of the surge and the positive urine test. It is advisable to test in the afternoon or evening, with insemination the following morning.

IVF is an effective treatment for the male factor because with intracytoplasmic sperm injection (ICSI), only one motile sperm for each egg is required. Finally, insemination with donor sperm is effective when the male factor is refractory to treatment.

OVULATORY FACTOR

Treatment

Use of fertility drugs such as clomiphene citrate or gonadotropins will correct any luteal insufficiency in women with unexplained infertility.

In women whose menses are less frequent than every 35 days (oligomenorrhea), it is helpful to induce more frequent ovulation, thus increasing the opportunity for pregnancy and improving the ability to time coitus. Ovulation induction should always be preceded by a thorough workup, as discussed in Chapter 32, because conditions causing anovulation may be worsened by pregnancy or may complicate it. In addition, ovarian failure seldom responds to attempts to induce ovulation.

The choice of the most appropriate technique for ovulation induction is determined by the patient’s specific diagnosis. With this approach, regular ovulation can be restored in more than 90% of anovulatory women. Provided that these patients persevere with treatment for an adequate period of time, and no other infertility factors are present, their fertility should approximate that of normal women.

Pituitary insufficiency requires the injection of hMG (follicle-stimulating hormone [FSH] and LH). Hypothalamic amenorrhea is caused by infrequent or absent pulsatile release of gonadotropin-releasing hormone (GnRH). GnRH is highly effective when administered in small pulses subcutaneously or intravenously in these patients every 90 to 120 minutes by a small portable infusion pump. Because this treatment is not currently as available in the United States, hMG is used, but with a much higher risk for multiple pregnancy. Hyperprolactinemia and its suppressive effect on the hypothalamus are specifically treated by use of the dopamine agonists bromocriptine (Parlodel) and cabergoline (Dostinex).

Most of the remaining patients with anovulation have some form of polycystic ovarian syndrome (PCOS) and generally respond to clomiphene, an orally active antiestrogen. Anovulation occurs in patients with polycystic ovaries because of chronic, mild suppression of FSH release. These women often have both increased ovarian and increased adrenal androgen production. Clomiphene, by inhibiting the negative feedback effect of endogenous estrogen, causes a rise of FSH and stimulation of follicular maturation. One of the principal causes of excessive ovarian androgen production is higher circulating insulin concentrations because of insulin resistance. Metformin, which reduces glucose mobilization and increases insulin sensitivity, is currently being used together with clomiphene or gonadotropins to improve response as well as to reduce an excessive response to ovulation induction. Metformin can also be used alone and may result in ovulation and pregnancy.

Other treatments used to induce ovulation in PCOS are laparoscopic “ovarian drilling,” in which multiple small craters are created with laser or cautery, and dexamethasone, which increases the ovarian response to clomiphene. Surgery is not often recommended because of the possibility of causing scarring around the ovaries and tubes.

If ovulation does not occur with clomiphene, follicular development may be occurring, but the normal LH surge may fail to occur. This results in lack of follicular rupture. Assessment by serial pelvic ultrasonography and carefully timed hCG administration may lead to normal ovulation. If follicular maturation is not occurring, ovulation induction will require low-dose FSH or hMG.

The main complications of ovulation induction are related to excessive stimulation of the ovaries. Substantial enlargement of the ovary with clomiphene citrate can generally be avoided by examining the ovaries before each treatment course and by using the lowest effective dose. Cystic ovarian enlargement is not an uncommon complication of hMG treatment but almost always regresses spontaneously. The hyperstimulation syndrome is a critical illness associated with marked ovarian enlargement and exudation of fluid and protein into the peritoneal cavity. The use of serum estradiol measurements, transvaginal ultrasonic scanning, and low-dose gonadotropin has greatly reduced the incidence of hyperstimulation syndrome. When starting at 50 to 75 units and increasing the dose by 25 to 50 units every 7 days if follicular maturation is not detected, there is a marked reduction in the incidence of multifollicular development, hyperstimulation, and multiple pregnancy. Multiple pregnancy occurs in 6% to 8% of clomiphene citrate conceptions, with less than 1% of cases exceeding twins. Multiple gestation occurs in 20% to 30% of hMG conceptions, and 5% of these conceptions are multiple births of more than two. Ultrasonic monitoring reduces this risk if the hCG is withheld in the presence of an excessive number of mature follicles. Current use of a low-dose regimen of hMG or pure FSH reduces the overall risk for multiple pregnancy to about 5%.

UTERINE OR TUBAL FACTOR

Abnormalities of the uterine cavity are seldom the cause of infertility. Large submucosal myomas or endometrial polyps, as seen in Figure 34-1, may be associated with infertility and first-trimester spontaneous abortions. The role of intramural myomas is not clear, although myomectomy has been associated with conception in 40% to 50% of couples in uncontrolled series, and some studies with IVF have shown reduced conception with intramural myomas. Subserous fibroids do not affect fecundity.

Tubal occlusion may occur at three locations: the fimbrial end, the mid-segment, or the isthmus-cornu. Fimbrial occlusion is by far the most common. Prior salpingitis is a common cause of tubal occlusion, although about half of cases are not associated with any such history. Isthmic-cornual occlusion can be congenital or caused by mucus plugs, endometriosis, tubal adenomyosis, or prior infection. Mid-segment occlusion can be seen after surgery or infection with tuberculosis.

Investigations

Tubal abnormalities may be diagnosed by HSG or laparoscopy. To perform HSG, an occlusive cannula is placed in the cervix, and the instillation of a radiopaque dye is followed with image intensification under fluoroscopy. Selected radiographs are taken for permanent documentation (Figure 34-2). Anesthesia generally is not required. A water-soluble dye is used initially to confirm tubal patency because of the adverse effects of sequestration of an oil-based dye within the lumen of an occluded tube. If patency is confirmed, an oil-based dye may then be instilled because of its prominent therapeutic effect in women with unexplained infertility. If only one tube fills with dye, the hysterosalpingogram should be considered normal because this finding is usually, although not invariably, caused by the dye following the path of least resistance.

Serious infections can result from HSG. Confirmation of a normal pelvic examination and prophylactic doxycycline should reduce this risk to a minimum.

Treatment

In most circumstances, microsurgical tuboplasty is more effective than conventional surgical techniques for reversal of tubal occlusion. About 60% to 80% of patients achieve pregnancy after reversal of sterilization using microsurgical techniques. Tubal anastomosis may be carried out laparoscopically, with good results in experienced hands.

When performed for fimbrial occlusion, neosalpingostomy is associated with a success rate of 20% to 30%, although it has reached 40% with long-term follow-up. Most often this is done by laparoscopy. Because a hydrosalpinx reduces the success rate of IVF by about 50%, any hydrosalpinx not repaired should be removed or its communication with the uterus interrupted by cautery or clips.

For an isthmic-cornual occlusion caused by disease, clearing the obstruction with oral danazol has been reported when the occlusion coexists with peritoneal endometriosis. Selective catheterization has restored patency in most proximal occlusions and should be the first line of therapy. Microsurgical resection and reanastomosis are associated with a 50% to 60% pregnancy rate. If the intramural portion of the tube is occluded, reimplantation is required, with a new opening being made into the endometrial cavity. A substantially lower rate of success is achieved in this circumstance, a laparotomy is required, and similar success can be achieved with a single cycle of IVF.

At least 10% of conceptions after repair of diseased tubes are ectopic pregnancies. Anastomosis of healthy tubes carries a risk for ectopic pregnancy of about 3% to 5%. This possibility must always be considered in the management of an early pregnancy following tuboplasty.

PERITONEAL FACTOR

Laparoscopy identifies previously unsuspected pathologic conditions in 30% to 50% of women with unexplained infertility. Endometriosis is the most common finding. Periadnexal adhesions may be found and may hold the fimbriae away from the ovarian surface or entrap the released oocyte.

Endometriosis may interfere with tubal motility, cause tubal obstruction, or cause adhesions that directly disturb the pick-up of the oocyte by the fimbriae. Other mechanisms of endometriosis-associated infertility must exist as well because even minimal endometriosis has some negative effect. In a randomized study of laparoscopic cautery versus no treatment for minimal endometriosis, treatment resulted in one of eight affected women conceiving. These same women, however, may conceive with other treatments used for unexplained infertility. There is a strong trend toward omitting laparoscopy in women who have no symptoms indicating pelvic disease and who have a normal pelvic examination, a normal HSG, and a normal pelvic ultrasound. A serum titer for antichlamydia antibodies may be helpful if this approach is taken, to avoid overlooking occult pelvic adhesions.

Treatment of endometriosis depends on its extent and is discussed further in Chapter 25. If substantial adhesions or endometriomas are present, laparoscopic surgery is preferable because these conditions generally do not respond to medical management. With advanced operative laparoscopic techniques, most endometriosis can be removed or ablated without laparotomy by using advanced instrumentation, lasers, or fulguration.

Danazol, GnRH agonists, and oral medroxyprogesterone acetate are effective treatments for symptomatic disease, with continuous oral contraception therapy being generally inferior. If minimal disease with scattered implants is found, simple cautery at the time of laparoscopy should suffice.

Periadnexal adhesions may be lysed by operative laparoscopy. Microsurgical techniques diminish adhesions. The most effective adjunct in preventing recurrent scarring is the placement of an artificial tissue barrier, separating the raw surfaces during the early period of healing.

Because of the current high success rate with IVF, that treatment is often done as an alternative to the above surgeries. It is particularly important to conserve ovarian function as much as possible. If ovarian reserve is low, IVF is preferable to removal of an endometrioma, because of the compromised ovarian function that often results from ovarian surgery.

image Assisted Reproductive Technologies

The last resort for infertile couples with any of the aforementioned factors and failure of lesser treatments is the procedure of IVF and embryo transfer (Figure 34-3). In most cases of tubal occlusion in which the rate of success with tubal repair is low (<30%), IVF is preferable to surgery because of the more rapid conception rate and the lower ectopic pregnancy rate. Even severe male factors can be effectively treated with IVF by using intracytoplasmic sperm injection, with high fertilization rates of injected oocytes and pregnancy rates similar to those of non–male-factor IVF (30% to 35%).